November 5th, 2026GC–MS and LC–MS Map Heart Tissue in Valve DiseaseGas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.Read more
November 5th, 2026GLP-1 Peptide Analysis: Challenges and SolutionsHow can advanced separations, inert hardware, orthogonal methods, and AI solve key challenges in reliable GLP-1 peptide analysis workflows?Read more
November 4th, 2026Sphingolipid LC–MS/MS: Anorexia vs. ObesityLiquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.Read more
November 4th, 2026AI/ML Now: Uncertainty-Driven Model-Based Search Methods for Method Development in Liquid Chromatography (Part Two)Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.Read more
November 4th, 2026AI/ML Now: Uncertainty-Driven Model-Based Search Methods for Method Development in Liquid Chromatography (Part One)Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.Read more
November 4th, 2026LC–MS Metabolomics Links Blood Molecules to LupusLiquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.Read more
November 4th, 2026Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILionLiquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.Read more
November 3rd, 2026LC–MS/MS Dried Blood Spot Test for GalactosemiaLiquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.Read more